CVE-2022-47986
CVE-2022-47986 is a critical-severity vulnerability (CVSS 3.1 base score 9.8). IBM Aspera Faspex could allow a remote attacker to execute code on the system, caused by a YAML deserialization flaw. CISA added it to the Known Exploited Vulnerabilities catalog on 2023-02-21, with a remediation due date of 2023-03-14 for US federal civilian agencies. CISA lists known use in ransomware campaigns. As of 2026-11-22, EPSS estimates a 99.965% probability of exploitation in the next 30 days, in the 99th percentile of scored CVEs.
Updated
- CVSS 3.1
- 9.8 CRITICAL
- EPSS
- 99.965% (99th pct)
- CISA KEV
- Exploited
- Published
- 2023-02-17
- Weakness
- CWE-502
IBM Aspera Faspex Code Execution Vulnerability is confirmed as actively exploited and is listed in the CISA KEV catalog.
Required action
Apply updates per vendor instructions.
CISA notes
https://exchange.xforce.ibmcloud.com/vulnerabilities/243512?_ga=2.189195179.1800390251.1676559338-700333034.1676325890; https://nvd.nist.gov/vuln/detail/CVE-2022-47986
Description
IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the system, caused by a YAML deserialization flaw. By sending a specially crafted obsolete API call, an attacker could exploit this vulnerability to execute arbitrary code on the system. The obsolete API call was removed in Faspex 4.4.2 PL2. IBM X-Force ID: 243512.
Key Findings
as of 2026-11-22- CISA added CVE-2022-47986 to the KEV catalog 4 days after its CVE record was published. The median for entries added in 2023 is 12 days.
- It is one of 9 IBM entries in the CISA KEV catalog, and the only one added in 2023.
- Its current EPSS score (99.965%) is higher than that of 94% of CISA KEV entries.
Severity
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HOpen in CVSS calculator Remediation Timeline
BOD 26-04, US federal agenciesDeadlines for US federal civilian agencies under Table 1 of CISA BOD 26-04, from the CVE's KEV status (listed) and CISA's SSVC values (automatable yes, technical impact total, 2025-01-29).
How the timeline is set
Table 1 of CISA's Binding Operational Directive 26-04 sets the time US federal civilian agencies have to remediate a vulnerability. It depends on four inputs: whether the asset is publicly exposed, whether the CVE is in the KEV catalog, whether an adversary can automate its exploitation, and whether exploitation gives partial or total control of the asset, which SSVC calls technical impact. CISA publishes the last three for every CVE through services such as its Vulnrichment program.
Days are calendar days. The clock starts at whichever comes first: CISA adds the CVE to the KEV catalog, or the agency identifies the vulnerability on an asset and reports it to its Continuous Diagnostics and Mitigation (CDM) dashboard. A publicly exposed asset is accessible to unauthenticated or untrusted entities via public networks, such as the internet. Forensic triage means assessing the asset to determine whether it has been compromised.
CISA calculates the KEV due date with the same table, using its own evidence on whether the vulnerability is present in a publicly exposed asset. Each agency makes the final exposure decision for each of its assets.
Affected Products
| Vendor | Product | Affected versions |
|---|---|---|
| IBM | IBM Aspera Faspex | 4.4.2 Patch Level 1 and earlier |
References
3 linksVendor advisories
Vulnerability databases
Other references
Record Details
- Published
- 2023-02-17
- Last updated
- 2025-10-21
- Assigner (CNA)
- ibm
- Credited to
- -
More from IBM
IBM Aspera Faspex Authorization Bypass
IBM Planning Analytics Remote Code Execution Vulnerability
IBM Data Risk Manager Security Bypass Vulnerability
IBM Data Risk Manager Directory Traversal Vulnerability
CVE record data © The MITRE Corporation, used under the CVE Terms of Use. Exploited-in-the-wild data from the CISA Known Exploited Vulnerabilities catalog (CC0). Exploit prediction scores by FIRST EPSS (first.org/epss). Alert titles and links from CISA cybersecurity alerts. This site is not affiliated with or endorsed by MITRE, NVD, CISA, or FIRST.